160 related articles for article (PubMed ID: 37006208)
1. The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma.
Narwal A; Kumari K; Kaushal S; Seth A; Nayak B; Rustagi Y; Dinda AK
Urol Ann; 2023; 15(1):35-42. PubMed ID: 37006208
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Epithelial-Mesenchymal Transition Markers "E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63" in Bladder Carcinoma.
Moussa RA; Khalil EZI; Ali AI
World J Oncol; 2019 Dec; 10(6):199-217. PubMed ID: 31921376
[TBL] [Abstract][Full Text] [Related]
3. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
Singh R; Singh UP; Agrawal V; Garg M
Mol Biol Rep; 2022 Aug; 49(8):7541-7556. PubMed ID: 35593896
[TBL] [Abstract][Full Text] [Related]
5. miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Sharma A; Pushker N; Kashyap S; Bakhshi S; Bajaj MS
Br J Ophthalmol; 2017 Apr; 101(4):536-542. PubMed ID: 28119291
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
Liu B; Miyake H; Nishikawa M; Fujisawa M
Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
[TBL] [Abstract][Full Text] [Related]
8. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.
Lee H; Jun SY; Lee YS; Lee HJ; Lee WS; Park CS
Virchows Arch; 2014 Feb; 464(2):213-20. PubMed ID: 24306957
[TBL] [Abstract][Full Text] [Related]
9. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
[TBL] [Abstract][Full Text] [Related]
11. Novel ZEB1 expression in bladder tumorigenesis.
Kenney PA; Wszolek MF; Rieger-Christ KM; Neto BS; Gould JJ; Harty NJ; Mosquera JM; Zeheb R; Loda M; Darling DS; Libertino JA; Summerhayes IC
BJU Int; 2011 Feb; 107(4):656-63. PubMed ID: 20735391
[TBL] [Abstract][Full Text] [Related]
12. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
Singh R; Mandhani A; Agrawal V; Garg M
Cancer Microenviron; 2018 Jun; 11(1):23-39. PubMed ID: 29349669
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells.
Neves R; Scheel C; Weinhold S; Honisch E; Iwaniuk KM; Trompeter HI; Niederacher D; Wernet P; Santourlidis S; Uhrberg M
BMC Res Notes; 2010 Aug; 3():219. PubMed ID: 20682048
[TBL] [Abstract][Full Text] [Related]
14. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
15. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Tripathi K; Maurya N; Goel A; Singhai A; Garg M
Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles.
Shash LS; Ibrahim RA; Elgohary SA
Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):657-666. PubMed ID: 33979097
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.
Zhang J; Zhang H; Qin Y; Chen C; Yang J; Song N; Gu M
Ann Transl Med; 2019 Apr; 7(7):141. PubMed ID: 31157262
[TBL] [Abstract][Full Text] [Related]
19. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
20. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
